Back to Search
Start Over
Differences in clinical outcomes of bloodstream infections caused by Klebsiella aerogenes, Klebsiella pneumoniae and Enterobacter cloacae: a multicentre cohort study.
- Source :
-
Annals of clinical microbiology and antimicrobials [Ann Clin Microbiol Antimicrob] 2024 May 06; Vol. 23 (1), pp. 42. Date of Electronic Publication: 2024 May 06. - Publication Year :
- 2024
-
Abstract
- Background: Klebsiella aerogenes has been reclassified from Enterobacter to Klebsiella genus due to its phenotypic and genotypic similarities with Klebsiella pneumoniae. It is unclear if clinical outcomes are also more similar. This study aims to assess clinical outcomes of bloodstreams infections (BSI) caused by K. aerogenes, K. pneumoniae and Enterobacter cloacae, through secondary data analysis, nested in PRO-BAC cohort study.<br />Methods: Hospitalized patients between October 2016 and March 2017 with monomicrobial BSI due to K. aerogenes, K. pneumoniae or E. cloacae were included. Primary outcome was a composite clinical outcome including all-cause mortality or recurrence until 30 days follow-up. Secondary outcomes were fever ≥ 72 h, persistent bacteraemia, and secondary device infection. Multilevel mixed-effect Poisson regression was used to estimate the association between microorganisms and outcome.<br />Results: Overall, 29 K. aerogenes, 77 E. cloacae and 337 K. pneumoniae BSI episodes were included. Mortality or recurrence was less frequent in K. aerogenes (6.9%) than in E. cloacae (20.8%) or K. pneumoniae (19.0%), but statistical difference was not observed (rate ratio (RR) 0.35, 95% CI 0.08 to 1.55; RR 0.42, 95% CI 0.10 to 1.71, respectively). Fever ≥ 72 h and device infection were more common in K. aerogenes group. In the multivariate analysis, adjusted for confounders (age, sex, BSI source, hospital ward, Charlson score and active antibiotic therapy), the estimates and direction of effect were similar to crude results.<br />Conclusions: Results suggest that BSI caused by K. aerogenes may have a better prognosis than E. cloacae or K. pneumoniae BSI.<br /> (© 2024. The Author(s).)
- Subjects :
- Humans
Male
Female
Aged
Middle Aged
Cohort Studies
Aged, 80 and over
Anti-Bacterial Agents therapeutic use
Anti-Bacterial Agents pharmacology
Recurrence
Treatment Outcome
Enterobacter cloacae isolation & purification
Klebsiella pneumoniae isolation & purification
Klebsiella pneumoniae drug effects
Bacteremia microbiology
Bacteremia mortality
Klebsiella Infections mortality
Klebsiella Infections microbiology
Klebsiella Infections drug therapy
Enterobacter aerogenes isolation & purification
Enterobacteriaceae Infections microbiology
Enterobacteriaceae Infections mortality
Subjects
Details
- Language :
- English
- ISSN :
- 1476-0711
- Volume :
- 23
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Annals of clinical microbiology and antimicrobials
- Publication Type :
- Academic Journal
- Accession number :
- 38711045
- Full Text :
- https://doi.org/10.1186/s12941-024-00700-8